NEUROD1 and small cell lung carcinoma: The remaining category, lacking dominant expression of ASCL1, NEUROD1, and POU2F3, is referred to as inflammatory SCLC (SCLC-I) or triple-negative SCLC (SCLC-TN) [8-10].